NFKB1 and neoplasm: In combination therapy, ferroptosis was suppressed, apoptosis and necroptosis were dominant, and NF-κB expression in the nucleus was suppressed across all treatments, with the combination therapy showing additive anti-tumor effects through programmed cell deaths and NF-κB signal modification [102].